Araclon Biotech
2004
FOUNDED
M&A
STATUS
M&A
LATEST DEAL TYPE
Description
Provider of biotechnology related services. Developer of therapies and diagnostic methods for Alzheimer's disease. The company focuses on research and development of therapies and diagnostic methods to be applied to degenerative diseases.
Website
Ownership Status
Acquired/Merged
(Operating Subsidiary)
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Office
- Vía Hispanidad
- 21 50009 Zaragoza
- Spain
+34 976 00 00 00
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Araclon Biotech’s full profile, request a free trial.
Araclon Biotech Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Merger/Acquisition | 15-Mar-2012 | Completed | Generating Revenue | |||
| 2. IBO | 15-Feb-2012 | Completed | Generating Revenue | |||
| 1. Early Stage VC | Completed | Generating Revenue |
Araclon Biotech Former Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Going Investment | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Mobius Venture Capital | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| VIA Technologies | Corporation | Minority | 000 0000 | 000000 0 |